Mitoepigenetic Alterations in Early-Onset Parkinson’s Disease
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27042033 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Rana Abu Manneh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Neuroepidemiology Department, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus. Hauptthemen laut MEDLINE: Parkinson Disease, DNA Methylation, Epigenesis, Genetic, DNA, Mitochondrial. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Michael J. Fox Foundation, Telethon Cyprus, Michael J. Fox Foundation.
Abstract (Originalsprache)
There is accumulating evidence that distinct mitochondrial DNA (mtDNA) methylation and hydroxymethylation patterns exist in Parkinson’s disease (PD). However, most studies have been limited to the investigation of specific target regions, rather than the entire mtDNA, and have been further hindered by other methodological discrepancies and the lack of non-CpG context investigation. Here, we provide a comprehensive profile of methylation and hydroxymethylation levels across the mitochondrial genome, at global and single-base resolution, in CpG and non-CpG (CHG, CHH) contexts in blood samples from early-onset PD (EOPD) patients (n = 39) and age- and sex-matched controls (n = 63). Bisulfite (BS) and oxidative-bisulfite (oxBS) conversions in parallel workflows followed by next-generation sequencing (NGS) using Illumina’s Novaseq 6000 sequencing system identified mitochondrial 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) in all contexts. Global mtDNA methylation was significantly higher in EOPD patients vs. matched controls in the CpG context (p = 5.63 × 10−3) in the BS status, and in all contexts [CpG (p = 2.67 × 10−4), CHG (p = 0.015), CHH (p = 0.012)] in the oxBS status, i.e., “true methylation”. At single-base resolution, the most statistically significant sites across the mitogenome, in the D-loop region, and CpG context, were primarily hypomethylated in EOPD patients compared to matched controls. Upon further validation, both global and base resolution mtDNA (hydroxy)methylation results could act as blood-based biomarkers for EOPD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neuroepidemiology Department, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus.
- Cancer Genetics, Therapeutics & Ultrastructural Pathology Department, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus.
- Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus.
- Department of Psychology, University of Cyprus, Nicosia 1678, Cyprus.
- Neuroimmunology Department, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus.
ORCID-Profile: Rana Abu Manneh, Paraskevi P Chairta, Maria A Loizidou, Maria Zanti, Andrea N Georgiou, Kyriaki Michailidou, Christiana Demetriou, Marios Pantzaris, Andreas Hadjisavvas
Förderung
- The Michael J. Fox Foundation
- Telethon Cyprus
- Michael J. Fox Foundation
Zitieren
APA
Abu Manneh, R., Chairta, P. P., Loizidou, M. A., Zanti, M., Georgiou, A. N., Michailidou, K., Demetriou, C., Pantzaris, M., Zamba-Papanicolaou, E., & Hadjisavvas, A. (2026). Mitoepigenetic Alterations in Early-Onset Parkinson’s Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27042033
Vancouver
Abu Manneh R, Chairta PP, Loizidou MA, Zanti M, Georgiou AN, Michailidou K, et al. Mitoepigenetic Alterations in Early-Onset Parkinson’s Disease. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27042033
BibTeX
@article{AbuManneh2026,
author = {Abu Manneh, Rana and Chairta, Paraskevi P and Loizidou, Maria A and Zanti, Maria and Georgiou, Andrea N and Michailidou, Kyriaki and Demetriou, Christiana and Pantzaris, Marios and Zamba-Papanicolaou, Eleni and Hadjisavvas, Andreas},
title = {Mitoepigenetic Alterations in Early-Onset Parkinson’s Disease},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27042033}
}
EUVIMED